<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01503346</url>
  </required_header>
  <id_info>
    <org_study_id>100610</org_study_id>
    <secondary_id>Protocol Record 100610</secondary_id>
    <nct_id>NCT01503346</nct_id>
  </id_info>
  <brief_title>DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients</brief_title>
  <acronym>TCM</acronym>
  <official_title>Taking Herbal Formula：DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients in Late-stage：A Clinical Control Trial Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yu-De Liu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Changhua Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Changhua Christian Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Appetite loss is a severe and common symptom among late-stage cancer patients, and it causes
      great the anxiety for the patient's family. In TCM theory, the investigators call these
      patients are in block and repulsion condition. The investigators try to set a study to use
      the herbal medicine solution taken in frequent small amounts by cancer patients in late-stage
      to improve the appetite loss condition. Through this method, the investigators not only want
      to improve the quality of life of cancer patients in late-stage but also set a valuable
      treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intervention group

        -  1. 2 grams of DaHuang abstract powder and 0.5 grams GanTsao abstract powder are mixed
           and separated into four packages;

        -  2. each package was given to each patient four times a day (three time after meal and
           one time before sleep);

        -  3. each patient received the usual medication of the hospice ward at the same time;

        -  4. record the patients' score of pre-test, mid-test and after-test of QIPCTP at the 1st
           day, the 3rd day and the 6th day;

        -  5. record the patients' score of EORTC QLQ-C30 V3.0 and ECOG (Eastern Cooperative
           Oncology Group Performance Status) at the 1st day and the 6th day.

      Control group

        -  1. each patient received the usual medication of the hospice ward during the trial
           interval;

        -  2. record the patients' score of receive pre-test, mid-test and after-test of QIPCTP at
           the 1st day, the 3rd day and the 6th day;

        -  3. record the patients' score of EORTC QLQ-C30 V3.0 and ECOG (Eastern Cooperative
           Oncology Group Performance Status) at at the 1st day and the 6th day.

      Medicine DaHuang herbal abstract powder is produced by Sun Ten Pharmaceutical Co., Ltd, and
      it's product serial number: 276001. GanCao herbal abstract powder is also produced by Sun Ten
      Pharmaceutical Co., Ltd, and it's product serial number: 185645. Each herbal abstract powder
      is qualified with the data of HPLC to confirm each content and stability. The pharmaceutical
      company is qualified by Good Manufacturing Practice (GMP) certification in Taiwan.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">March 2012</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>appetite score</measure>
    <time_frame>6 days</time_frame>
    <description>The investigators detect the patients' appetite condition at the 1st,3rd and 6th day.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Non-organic Loss of Appetite</condition>
  <arm_group>
    <arm_group_label>herbal medicine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention group
1. 2 grams of DaHuang abstract powder and 0.5 grams GanTsao abstract powder are mixed and separated into four packages;
2. each package was given to each patient four times a day (three time after meal and one time before sleep);
3. each patient received the usual medication of the hospice ward at the same time;
4. record the patients' score of pre-test, mid-test and after-test of QIPCTP at the 1st day, the 3rd day and the 6th day;
5. record the patients' score of EORTC QLQ-C30 V3.0 and ECOG (Eastern Cooperative Oncology Group Performance Status) at the 1st day and the 6th day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DaHuang GanTsao Tang</intervention_name>
    <description>Intervention group
2 grams of DaHuang abstract powder and 0.5 grams GanTsao abstract powder are mixed and separated into four packages;
each package was given to each patient four times a day (three time after meal and one time before sleep);
each patient received the usual medication of the hospice ward at the same time;
record the patients' score of pre-test, mid-test and after-test of QIPCTP at the 1st day, the 3rd day and the 6th day;
record the patients' score of EORTC QLQ-C30 V3.0 and ECOG (Eastern Cooperative Oncology Group Performance Status) at the 1st day and the 6th day.</description>
    <arm_group_label>herbal medicine</arm_group_label>
    <other_name>Herbal Medicine Group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Terminal cancer patients in hospice ward

          -  Patients with appetite loss condition

          -  Ages between 20 to 80 years old

          -  No history of diabetes

        Exclusion Criteria:

          -  Entered the stage of dying patients

          -  Receiving other traditional Chinese medicine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu De LIU, Master</last_name>
    <role>Study Chair</role>
    <affiliation>Changhua Christian Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Y D LIU, Master</last_name>
    <phone>886-988-285196</phone>
    <email>lude961031@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>S C YANG, Master</last_name>
    <phone>886-937-251181</phone>
    <email>a884215@gmailc.om</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Changhua Christan Hospital</name>
      <address>
        <city>Changhua City</city>
        <state>Changhua Country</state>
        <zip>500</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Y D LIU, Master</last_name>
      <phone>886-988-285196</phone>
      <email>lude961031@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>S C YANG, Master</last_name>
      <phone>886-937-251181</phone>
      <email>a884215@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2011</study_first_submitted>
  <study_first_submitted_qc>January 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2012</study_first_posted>
  <last_update_submitted>January 3, 2012</last_update_submitted>
  <last_update_submitted_qc>January 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Changhua Christian Hospital</investigator_affiliation>
    <investigator_full_name>Yu-De Liu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Appetite Loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

